Envoy Medical

Envoy Medical Current Liabilities

The Current Liabilities of Envoy Medical (COCH) as of Nov 2, 2026 is 11.56 M USD. In the previous year, Current Liabilities was 11.41 M USD — a change of 1.37% (higher).

Current Liabilities

11.56 MUSD

YoY

1.37%

Last updated:

Current Liabilities of Envoy Medical is 2025 11.56 M USD. Current Liabilities of Envoy Medical was 2024 11.41 M USD. It decreases by 1.37% higher compared to the previous year.

The Envoy Medical Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2020
100,000.00 USD
Jan 1, 2021
3.88 M USD
Jan 1, 2022
6.40 M USD
Jan 1, 2023
12.06 M USD
Jan 1, 2024
11.41 M USD
Jan 1, 2025
11.56 M USD
The Envoy Medical Current Liabilities history
YEARCurrent LiabilitiesYoY
11.56 MUSD+1.37%
11.41 MUSD-5.39%
12.06 MUSD+88.43%
6.40 MUSD+65.11%
3.88 MUSD+3,775.00%
100,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Envoy Medical Stock analysis

What does Envoy Medical do? Envoy Medical Inc generates revenue through its portfolio of hearing health solutions including hearing aids, middle ear implants, bone conduction devices, and cochlear implants. The company's Esteem is a fully implanted active middle ear implant targeting adults with moderate to severe sensorineural hearing loss. Bone conduction devices feature an external component paired with a surgically implanted fixture behind the ear, offering amplification without ear molds. Hearing aids serve patients with mild to moderate hearing loss, while cochlear implants address moderate-to-profound sensorineural hearing loss. These products are sold to healthcare providers and patients seeking advanced hearing solutions within the hearing loss spectrum. The company's business model focuses on providing medical technologies that shift industry paradigms, with products designed for different severity levels of hearing loss. Hearing aids target mild to moderate cases, while cochlear implants and Esteem address more severe conditions. Bone conduction devices specifically eliminate the need for ear molds by using bone conduction technology. All solutions are positioned to serve both providers and patients requiring specialized hearing devices across the hearing loss spectrum. Envoy Medical Inc's revenue streams come from direct sales of its hearing devices to healthcare providers who then serve patients. The company's product range spans from non-invasive hearing aids for mild cases to fully implanted solutions like Esteem for severe hearing loss. Each product category targets specific patient segments based on hearing loss severity, ensuring tailored solutions for different needs within the hearing health market. Envoy Medical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Envoy Medical stock

Current Liabilities of Envoy Medical is 11.56 M USD in 2025.

Current Liabilities of Envoy Medical changed from 11.41 M USD to 11.56 M USD, representing a 1.37% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Envoy Medical since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Envoy Medical historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Envoy Medical

All Key Metrics — Envoy Medical